SAN DIEGO--(BUSINESS WIRE)--May 15, 2006--IDM Pharma, Inc. (Nasdaq: IDMI - News) today announced its financial results for the first quarter ended March 31, 2006. Financial information for the three months ended March 31, 2006 represents the consolidated results of IDM Pharma (formerly Epimmune Inc.) and its subsidiary, IDM S.A., following the completion of their business combination on August 16, 2005. Financial information for the three months ended March 31, 2005 represents the historical financial information for IDM S.A. which was deemed to be the acquirer in the business combination for accounting purposes.
